Aprepitant Intravenous Emulsion Based on Ion Pairing/Phospholipid Complex for Improving Physical and Chemical Stability During Thermal Sterilization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aprepitant Intravenous Emulsion Based on Ion Pairing/Phospholipid Complex for Improving Physical and Chemical Stability During Thermal Sterilization

Published:2020-01-21 Issue:3 Volume:21 Page:
ISSN:1530-9932
Container-title:AAPS PharmSciTech
language:en
Short-container-title:AAPS PharmSciTech

Author:

Zhang Xinyu,Wei Ying,Cao Zhijun,Xu Ying,Lu Cong,Zhao Meiqi,Gou Jingxin,Yin Tian,Zhang Yu,He Haibing,Wang Yanjiao,Tang Xing

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics

Link

http://link.springer.com/content/pdf/10.1208/s12249-019-1605-7.pdf

Reference40 articles.

1. Ballatori E, Roila F. Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes. 2003;1:46.

2. T. Ottoboni, M. Lauw, M.R. Keller, M. Cravets, K. Manhard, N. Clendeninn, B. Quart, Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects, Future Oncol, (2018) fon-2018-0311-.

3. Angi R, Solymosi T, Ötvös Z, Ordasi B, Glavinas H, Filipcsei G, et al. Novel continuous flow technology for the development of a nanostructured aprepitant formulation with improved pharmacokinetic properties. Eur J Pharm Biopharm. 2014;86:361–8.

4. Rapoport B, Chua D, Poma A, Arora S, Wang Y, Fein LE. Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC). Support Care Cancer. 2015;23:3281–8.

5. Saito H, Yoshizawa H, Yoshimori K, Katakami N, Katsumata N, Kawahara M, et al. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Ann Oncol. 2012;24:1067–73.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoemulsion based lipid nanoparticles for effective demethylcantharidin delivery to cure liver cancer;Chemical Biology & Drug Design;2024-07

2. Improving the Physicochemical Stability of Soy Phospholipid-Stabilized Emulsions Loaded with Lutein by the Addition of Sphingomyelin and Cholesterol: Inspired by a Milk Fat Globule Membrane;Journal of Agricultural and Food Chemistry;2023-10-10

3. Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex;Drug Delivery;2023-02-27

4. Formulation and Physicochemical and Biological Characterization of Etoposide-Loaded Submicron Emulsions with Biosurfactant of Sophorolipids;AAPS PharmSciTech;2022-07-01

5. Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity;Expert Opinion on Drug Delivery;2022-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3